C. Frank Bennett - Sep 28, 2023 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
EVP, Chief Scientific Officer
Signature
By: Patrick R. O'Neil, attorney-in-fact For: C. Frank Bennett
Stock symbol
IONS
Transactions as of
Sep 28, 2023
Transactions value $
-$207,390
Form type
4
Date filed
9/29/2023, 05:20 PM
Previous filing
Sep 5, 2023
Next filing
Dec 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Sale -$207K -4.46K -6.35% $46.50 65.8K Sep 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 29, 2023